0.32
price down icon0.40%   -0.0013
pre-market  Pre-mercato:  .32  
loading

Allakos Inc Borsa (ALLK) Ultime notizie

pulisher
Apr 03, 2025

Allakos Inc (ALLK) Recovers 48.96% From Low: Are We There Yet? - stocksregister.com

Apr 03, 2025
pulisher
Apr 03, 2025

Allakos And 2 Other Promising Penny Stocks To Watch - simplywall.st

Apr 03, 2025
pulisher
Apr 03, 2025

Short Interest in Allakos Inc. (NASDAQ:ALLK) Decreases By 13.9% - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Allakos Inc.ALLK - PR Newswire

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos Inc Inc. (ALLK) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 02, 2025
pulisher
Apr 02, 2025

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Allakos, Inc. (ALLK) - TradingView

Apr 02, 2025
pulisher
Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Apr 02, 2025
pulisher
Apr 02, 2025

Tang Capital’s Concentra nabs a win, making a deal to buy Allakos - Endpoints News

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos to be acquired by Concentra Biosciences for 33c per share in cash - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

ALLK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Allakos Inc. Is Fair to Shareholders - The Joplin Globe

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos Announces Merger Agreement with Concentra Biosciences - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Shareholder Alert: The Ademi Firm Investigates Whether Allakos Inc. Is Obtaining a Fair Price for Its Public Shareholders - Bluefield Daily Telegraph

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos agrees to Concentra Biosciences acquisition - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos stock surges on reverse merger deal (ALLK:NASDAQ) - Seeking Alpha

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos to Be Acquired for 33 Cents a Share - MarketWatch

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share - The Manila Times

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos Inc. Enters Into Agreement To Be Acquired By Concentra Biosciences - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos (ALLK) Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share - StreetInsider

Apr 02, 2025
pulisher
Apr 02, 2025

Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in - Bluefield Daily Telegraph

Apr 02, 2025
pulisher
Apr 02, 2025

Biotech Deal Alert: Concentra Biosciences Acquires AllakosKey Terms Revealed - Stock Titan

Apr 02, 2025
pulisher
Apr 01, 2025

ALLK ALERT: ROSEN, A LEADING FIRM, Reminds Allakos Inc. Investors of Important May 11th Deadline in Securities Class Action First Filed By Firm- ALLK - ACCESS Newswire

Apr 01, 2025
pulisher
Mar 26, 2025

Allakos stock plunges to 52-week low of $0.23 amid market challenges By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Allakos stock plunges to 52-week low of $0.23 amid market challenges - Investing.com India

Mar 26, 2025
pulisher
Mar 20, 2025

Shareholder Alert: The Ademi Firm investigates whether Optinose, Inc. is obtaining a Fair Price for its Public Shareholders - Business Wire

Mar 20, 2025
pulisher
Mar 20, 2025

Allakos Inc. (NASDAQ:ALLK) Short Interest Update - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

Analyzing Allakos (NASDAQ:ALLK) and Acerus Pharmaceuticals (OTCMKTS:TRLPF) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Allakos Inc.: Hold Rating Amid Restructuring and Financial Uncertainty - TipRanks

Mar 17, 2025
pulisher
Mar 14, 2025

Allakos faces potential Nasdaq delisting over share price By Investing.com - Investing.com Australia

Mar 14, 2025
pulisher
Mar 14, 2025

Allakos Reports Q4 2024 Results Amid Strategic Shift - TipRanks

Mar 14, 2025
pulisher
Mar 13, 2025

Allakos faces potential Nasdaq delisting over share price - Investing.com India

Mar 13, 2025
pulisher
Mar 12, 2025

Allakos Inc. (ALLK) reports earnings - Quartz

Mar 12, 2025
pulisher
Mar 12, 2025

Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results - The Manila Times

Mar 12, 2025
pulisher
Mar 12, 2025

Allakos Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 12, 2025
pulisher
Mar 12, 2025

Allakos Swings to Surprise Q4 Profit as Major Restructuring Takes Shape - StockTitan

Mar 12, 2025
pulisher
Mar 06, 2025

Allakos (ALLK) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 06, 2025
pulisher
Mar 01, 2025

The Curious Case of Allakos - substack.com

Mar 01, 2025
pulisher
Feb 26, 2025

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Allakos (ALLK) Investors with Losses to Contact Its Attorneys: 3 DAY APPLICATION DEADLINE ALERT - ACCESS Newswire

Feb 26, 2025
pulisher
Feb 22, 2025

Allakos Inc. (ALLK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Feb 22, 2025
pulisher
Feb 12, 2025

Lee joins Lycia as CMO - BioCentury

Feb 12, 2025
pulisher
Feb 11, 2025

It is Poised to be a Bull Market for Allakos Inc (ALLK) - SETE News

Feb 11, 2025
pulisher
Feb 10, 2025

Kuehn Law Encourages Investors of Allakos Inc. to Contact Law Firm - EIN News

Feb 10, 2025
pulisher
Feb 10, 2025

Introducing Our Rant Against Allakos Inc - US Post News

Feb 10, 2025
pulisher
Feb 08, 2025

FY2024 EPS Estimates for Allakos Lowered by Leerink Partnrs - Defense World

Feb 08, 2025
pulisher
Feb 07, 2025

Allakos Inc [ALLK] Officer makes an insider purchase of 21,116 shares worth 23219.0. - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

This Week’s 14.26% Gain In Allakos Inc (NASDAQ: ALLK) Taught Us Something New - Marketing Sentinel

Feb 07, 2025
pulisher
Feb 06, 2025

Evaluating Allakos: Strategic Review, NOL Potential, and Kevin Tang's Activist Stake Amidst Biopharma Challenges - Smartkarma

Feb 06, 2025
pulisher
Feb 05, 2025

What To Expect From Eli Lilly’s (LLY) Q4 Earnings - The Globe and Mail

Feb 05, 2025
pulisher
Feb 05, 2025

Chronic Spontaneous Urticaria Market Set to Grow Substantially - openPR

Feb 05, 2025
pulisher
Feb 05, 2025

Such Is The Power Of Allakos Inc (NASDAQ: ALLK) - Stocks Register

Feb 05, 2025
pulisher
Feb 04, 2025

Allakos Inc: -85.21% Growth from 52-Week Low, Yet Analysts Divided - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Allakos Inc - GuruFocus

Feb 04, 2025
pulisher
Feb 04, 2025

Allakos stock tanks after company announces mass layoffs - MSN

Feb 04, 2025
pulisher
Feb 03, 2025

The time has not yet come to remove your chips from the table: Allakos Inc (ALLK) - SETE News

Feb 03, 2025
pulisher
Feb 03, 2025

Allakos stock plunges to 52-week low of $0.23 amid steep annual decline - Investing.com

Feb 03, 2025
pulisher
Feb 01, 2025

Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok - Benzinga India

Feb 01, 2025
pulisher
Jan 31, 2025

Allakos stock tumbles following AK006 trial discontinuation - MSN

Jan 31, 2025
pulisher
Jan 30, 2025

Bay Area biotech firm guts staff, shuts trial after dangerous side effects - SFGATE

Jan 30, 2025
pulisher
Jan 30, 2025

Allakos plunges 75% on phase 1 data for urticaria asset - MSN

Jan 30, 2025
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Capitalizzazione:     |  Volume (24 ore):